INS and hepatocellular carcinoma: We further investigated the anti-proliferative effects of β-elemene in hepatocellular carcinoma cell HepG2, and β-elemene treatment also led to significant reduction of the insulin-driven cell growth in a dose-dependent manner (P < 0.01) (Fig. 3F and G).